SCHEMBL13006174

SCHEMBL13006174

COc1c(C=O)cccc1-c1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 11/20 0.53
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CYP19A1 P11511 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
FYN P06241 1/20 0.40
MAPT P10636 1/20 0.39
SRC P12931 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
TLR2 O60603 1/20 0.38
TLR1 Q15399 1/20 0.38
TLR6 Q9Y2C9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13006162 0.83 ERN1 (0.43) ERN1SMN1; SMN2ALDH1A1FYNMAPT
SCHEMBL13006172 0.82 ERN1 (0.57) ERN1SMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL4685731 0.80 CA1 (0.49) ERN1CA1CA2SRCTLR2
SCHEMBL5373060 0.78 CA1 (0.53) ERN1CA1CA2ALDH1A1SRC
SCHEMBL1642697 0.78 CA1 (0.56) ERN1CA1CA2ALDH1A1MAPT
SCHEMBL184461 0.77 CA1 (0.51) ERN1CA1CA2HPGDMAPT
SCHEMBL5737981 0.77 CA1 (0.51) ERN1CA1CA2ALDH1A1MAPT
SCHEMBL13006175 0.75 CYP1A2 (0.47) SMN1; SMN2ALDH1A1HPGDFYNCYP1A2
SCHEMBL5982536 0.74 CA1 (0.49) ERN1CA1CA2ALDH1A1MAPT
SCHEMBL15709668 0.74 CYP1A2 (0.53) ERN1SMN1; SMN2ALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed